Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isadora Rosa

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
United European Gastroenterology Journal|June 15, 2023
How many biomarker measurements are needed to predict prognosis in Crohn's disease patients under infliximab?-A prospective studyFernando Magro, Maria Manuela Estevinho, Gaia Catalano, et al.
Therapeutic Advances in Gastroenterology|November 3, 2016
Detection of anti-infliximab antibodies is impacted by antibody titer, infliximab level and IgG4 antibodies: a systematic comparison of three different assaysJoana Afonso, Susana Lopes, Raquel Gonçalves, et al.
Inflammatory Bowel Diseases|January 21, 2017
Impact of Early Surgery and Immunosuppression on Crohn's Disease Disabling OutcomesFernando Magro, Cláudia C Dias, Rosa Coelho, et al.
United European Gastroenterology Journal|December 28, 2022
Transmural remission improves clinical outcomes up to 5 years in Crohn's diseaseSamuel Raimundo Fernandes, Juliana Serrazina, Inês Ayala Botto, et al.
Journal of Crohn'S & Colitis|September 30, 2016
Development and Validation of Risk Matrices for Crohn's Disease Outcomes in Patients Who Underwent Early Therapeutic InterventionsCláudia Camila Dias, Pedro Pereira Rodrigues, Rosa Coelho, et al.
Journal of Crohn'S & Colitis|December 9, 2016
Erratum: Development and Validation of Risk Matrices for Crohn's Disease Outcomes in Patients Who Underwent Early Therapeutic InterventionsCláudia Camila Dias, Pedro Pereira Rodrigues, Rosa Coelho, et al.
Gut|February 14, 2018
Comparison of different histological indexes in the assessment of UC activity and their accuracy regarding endoscopic outcomes and faecal calprotectin levelsFernando Magro, Joanne Lopes, Paula Borralho, et al.
Journal of Crohn'S & Colitis|November 12, 2019
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical TreatmentJoana Torres, Stefanos Bonovas, Glen Doherty, et al.
Journal of Crohn'S & Colitis|November 20, 2019
ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical TreatmentMichel Adamina, Stefanos Bonovas, Tim Raine, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
United European Gastroenterology Journal|June 15, 2023
How many biomarker measurements are needed to predict prognosis in Crohn's disease patients under infliximab?-A prospective studyFernando Magro, Maria Manuela Estevinho, Gaia Catalano, et al.
Therapeutic Advances in Gastroenterology|November 3, 2016
Detection of anti-infliximab antibodies is impacted by antibody titer, infliximab level and IgG4 antibodies: a systematic comparison of three different assaysJoana Afonso, Susana Lopes, Raquel Gonçalves, et al.
Inflammatory Bowel Diseases|January 21, 2017
Impact of Early Surgery and Immunosuppression on Crohn's Disease Disabling OutcomesFernando Magro, Cláudia C Dias, Rosa Coelho, et al.
United European Gastroenterology Journal|December 28, 2022
Transmural remission improves clinical outcomes up to 5 years in Crohn's diseaseSamuel Raimundo Fernandes, Juliana Serrazina, Inês Ayala Botto, et al.
Journal of Crohn'S & Colitis|September 30, 2016
Development and Validation of Risk Matrices for Crohn's Disease Outcomes in Patients Who Underwent Early Therapeutic InterventionsCláudia Camila Dias, Pedro Pereira Rodrigues, Rosa Coelho, et al.
Journal of Crohn'S & Colitis|December 9, 2016
Erratum: Development and Validation of Risk Matrices for Crohn's Disease Outcomes in Patients Who Underwent Early Therapeutic InterventionsCláudia Camila Dias, Pedro Pereira Rodrigues, Rosa Coelho, et al.
Gut|February 14, 2018
Comparison of different histological indexes in the assessment of UC activity and their accuracy regarding endoscopic outcomes and faecal calprotectin levelsFernando Magro, Joanne Lopes, Paula Borralho, et al.
Journal of Crohn'S & Colitis|November 12, 2019
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical TreatmentJoana Torres, Stefanos Bonovas, Glen Doherty, et al.
Journal of Crohn'S & Colitis|November 20, 2019
ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical TreatmentMichel Adamina, Stefanos Bonovas, Tim Raine, et al.
Pageof 6